BBR Partners’s Sanofi SNY Stock Holding History

BBR Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,822	Closed	-$292K	–	202
2019 Q4	$292K	Buy	+5,822	New	+$273K	0.03%	150

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBR Partners's SNY Position: Q1 2020 in Review

BBR Partners sold out of Sanofi (SNY) in Q1 2020, closing a stake of 5,822 shares — an estimated $292K sold.

BBR Partners first reported a position in SNY in Q4 2019 and held it in 1 quarter. The position peaked at $292K in Q4 2019. 547 funds tracked by Wall St. Rank hold SNY as of Q1 2020.

BBR Partners reported no remaining Sanofi position as of Q1 2020 after selling out during the quarter.
BBR Partners sold 5,822 Sanofi shares in Q1 2020, an estimated $292K.
BBR Partners first reported a position in Sanofi in Q4 2019 and held it in 1 quarter.
BBR Partners's Sanofi position peaked at $292K in Q4 2019.
547 funds tracked by Wall St. Rank held Sanofi as of Q1 2020.

Based on BBR Partners's 13F filing for Q1 2020, filed 14 May 2020.